Open Access News

News from the open access movement


Friday, June 03, 2005

Questions about private funding of university research

Alan Ryan, Fading Ivy, Financial Times, June 3, 2005. A joint review of three recent books on research universities: Jennifer Washburn's University, Inc., Ross Gregory Douthat's Privilege, and Richard Bradley's Harvard Rules. This excerpt focuses on Washburn's book: '[Washburn's third thesis] is that since the public spends a great deal of money on the research done in universities, the public ought to get a fair share of the benefit. Otherwise, the public pays for the research twice over, first through its taxes and then through the profits made by the companies that exploit the research. The question is what a fair return to the public actually is. Might the public get a better bargain if the results of research remain available to anyone who wishes to use them, as part of the intellectual "commons"? And might the public have grounds for thinking that, if private sponsors fund research, the quality of what is produced should be more carefully policed than at present? When more than 90 per cent of papers reporting sponsored research into the effectiveness of drugs report positive findings, and only 60 per cent of non-sponsored research do so, anxiety about the corruption of the researcher's judgment - even inadvertent - is not misplaced. The temptation is to denounce the wickedness of corporate capitalism, university administrators and the other "usual suspects". Washburn is too intelligent to succumb to that temptation. Universities have been starved of public funding over the past two decades and can hardly be expected to pass up the offer of private funds; and the pace of innovation in fields such as bio-technology is such that no company can pass up the chance to be involved in research. What is needed is not a retreat into an ivory tower but better regulation.'